BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14757169)

  • 1. Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
    Andersson U; Reinkensmeier G; Butters TD; Dwek RA; Platt FM
    Biochem Pharmacol; 2004 Feb; 67(4):697-705. PubMed ID: 14757169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
    Andersson U; Butters TD; Dwek RA; Platt FM
    Biochem Pharmacol; 2000 Apr; 59(7):821-9. PubMed ID: 10718340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of α-glucosidase activity by N-deoxynojirimycin analogs in several insect phloem sap feeders.
    Ya'kobovitz MK; Butters TD; Cohen E
    Insect Sci; 2016 Feb; 23(1):59-67. PubMed ID: 25900765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
    Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.
    Platt FM; Neises GR; Karlsson GB; Dwek RA; Butters TD
    J Biol Chem; 1994 Oct; 269(43):27108-14. PubMed ID: 7929454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-specific antiviral activity of iminosugars against human influenza A viruses.
    Hussain S; Miller JL; Harvey DJ; Gu Y; Rosenthal PB; Zitzmann N; McCauley JW
    J Antimicrob Chemother; 2015 Jan; 70(1):136-52. PubMed ID: 25223974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
    Andersson U; Smith D; Jeyakumar M; Butters TD; Borja MC; Dwek RA; Platt FM
    Neurobiol Dis; 2004 Aug; 16(3):506-15. PubMed ID: 15262262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of alpha-glucosidases I and II increases the cell surface expression of functional class A macrophage scavenger receptor (SR-A) by extending its half-life.
    Tian G; Wilcockson D; Perry VH; Rudd PM; Dwek RA; Platt FM; Platt N
    J Biol Chem; 2004 Sep; 279(38):39303-9. PubMed ID: 15234963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
    Denny CA; Heinecke KA; Kim YP; Baek RC; Loh KS; Butters TD; Bronson RT; Platt FM; Seyfried TN
    J Neurochem; 2010 Jun; 113(6):1525-35. PubMed ID: 20374428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkylated imino sugars, reversible male infertility-inducing agents, do not affect the genetic integrity of male mouse germ cells during short-term treatment despite induction of sperm deformities.
    Suganuma R; Walden CM; Butters TD; Platt FM; Dwek RA; Yanagimachi R; van der Spoel AC
    Biol Reprod; 2005 Apr; 72(4):805-13. PubMed ID: 15576825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception.
    van der Spoel AC; Jeyakumar M; Butters TD; Charlton HM; Moore HD; Dwek RA; Platt FM
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17173-8. PubMed ID: 12477936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
    Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
    Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120.
    Karlsson GB; Butters TD; Dwek RA; Platt FM
    J Biol Chem; 1993 Jan; 268(1):570-6. PubMed ID: 8416962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy.
    Ouzounov S; Mehta A; Dwek RA; Block TM; Jordan R
    Antiviral Res; 2002 Sep; 55(3):425-35. PubMed ID: 12206880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
    Priestman DA; van der Spoel AC; Butters TD; Dwek RA; Platt FM
    Diabetes Obes Metab; 2008 Feb; 10(2):159-66. PubMed ID: 18190430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
    Platt FM; Neises GR; Dwek RA; Butters TD
    J Biol Chem; 1994 Mar; 269(11):8362-5. PubMed ID: 8132559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ.
    Mehta A; Ouzounov S; Jordan R; Simsek E; Lu X; Moriarty RM; Jacob G; Dwek RA; Block TM
    Antivir Chem Chemother; 2002 Sep; 13(5):299-304. PubMed ID: 12630678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
    Brumshtein B; Greenblatt HM; Butters TD; Shaaltiel Y; Aviezer D; Silman I; Futerman AH; Sussman JL
    J Biol Chem; 2007 Sep; 282(39):29052-29058. PubMed ID: 17666401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation.
    van der Spoel AC; Mott R; Platt FM
    Pharmacogenomics; 2008 Jun; 9(6):717-31. PubMed ID: 18518850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.
    Kuriyama C; Kamiyama O; Ikeda K; Sanae F; Kato A; Adachi I; Imahori T; Takahata H; Okamoto T; Asano N
    Bioorg Med Chem; 2008 Aug; 16(15):7330-6. PubMed ID: 18595718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.